{
  "@type": "Dataset",
  "accessLevel": "public",
  "accessRights": "public",
  "bureauCode": [
    "009:20"
  ],
  "contactPoint": [
    {
      "@type": "Kind",
      "fn": "Tuberculosis Epidemiologic Studies Consortium",
      "hasEmail": "mailto:tbesc3@cdc.gov"
    }
  ],
  "description": "This study used a mixed-methods approach to identify provider- and clinic-level barriers and facilitators in the latent tuberculosis infection (LTBI) care cascade at community health clinics. This included both qualitative and quantitative data collection.",
  "distribution": [
    {
      "@type": "Distribution",
      "accessURL": "https://data.cdc.gov/d/8xdf-byx4",
      "downloadURL": "https://data.cdc.gov/download/8xdf-byx4/application/x-zip-compressed",
      "mediaType": "application/x-zip-compressed",
      "modified": "2026-09-09"
    }
  ],
  "identifier": "https://data.cdc.gov/api/views/8xdf-byx4",
  "inventoried": "2026-09-27",
  "keyword": [
    "care cascade",
    "cascade of care",
    "latent tuberculosis infection (ltbi)",
    "tuberculosis (tb)"
  ],
  "landingPage": {
    "@type": "Document",
    "accessURL": "https://data.cdc.gov/d/8xdf-byx4",
    "description": "Tuberculosis Epidemiologic Studies Consortium (TBESC)-II Part C: Improving screening, testing, and treatment for latent TB infection (LTBI) - Dataset Home",
    "issued": "2025-03-14",
    "publisher": [
      {
        "@id": "https://data.cdc.gov/user/f2ch-h7gm",
        "@type": "Organization",
        "name": "CDC"
      }
    ],
    "title": "Tuberculosis Epidemiologic Studies Consortium (TBESC)-II Part C: Improving screening, testing, and treatment for latent TB infection (LTBI) - Dataset Home"
  },
  "license": "https://www.usa.gov/government-works",
  "modified": "2026-09-09",
  "programCode": [
    "009:027"
  ],
  "publisher": {
    "@id": "https://data.cdc.gov/user/f2ch-h7gm",
    "@type": "Organization",
    "name": "CDC"
  },
  "title": "Tuberculosis Epidemiologic Studies Consortium (TBESC)-II Part C: Improving screening, testing, and treatment for latent TB infection (LTBI)"
}